REBECCA SUTPHEN, MD
Medical Practice at Spectrum Blvd, Tampa, FL
License number
Florida ME61423
Category
Medical Practice
Type
Pediatrics
Address
Address
3650 Spectrum Blvd SUITE 100, Tampa, FL 33612
Phone
(813) 396-9234
Personal information
See more information about REBECCA SUTPHEN at radaris.comName
Address
Phone
2608 53Rd St S, Gulfport, FL 33707
11850 Dr Martin Luther King Jr St, Saint Petersburg, FL 33716
880 6Th St S, Saint Petersburg, FL 33701
Organization information
See more information about REBECCA SUTPHEN at bizstanding.comRebecca Sutphen MD
12902 Usf Magnolia Dr, Tampa, FL 33612
Industry:
Genetic Medicine, Pediatrician
Phone:
(813) 745-4673 (Phone)
Rebecca Sutphen
Professional information
President And Chief Medical Officer At Informeddna
Position:
President and Chief Medical Officer at InformedDNA, Professor at Morsani College of Medicine, University of South Florida
Location:
Tampa/St. Petersburg, Florida Area
Industry:
Hospital & Health Care
Work:
InformedDNA
- Tampa/St. Petersburg, Florida Area since 2006
-
President and Chief Medical Officer
Morsani College of Medicine, University of South Florida
- Tampa/St. Petersburg, Florida Area since 1996
-
Professor
Moffitt Cancer Center
Jul 1996 - Dec 2009
-
Director of Clinical Genetics
Education:
Temple University School of Medicine
M.D.
M.D.
Director, Clinical Genetics At Moffitt Cancer Center
Position:
Director, Clinical Genetics at Moffitt Cancer Center, Executive Vice President, Clinical Affairs at Informed Medical Decisions, Inc.
Location:
Tampa/St. Petersburg, Florida Area
Industry:
Hospital & Health Care
Work:
Moffitt Cancer Center
-
Director, Clinical Genetics
Informed Medical Decisions, Inc.
since 2006
-
Executive Vice President, Clinical Affairs
Dr. Rebecca Sutphen, Tampa FL - MD (Doctor of Medicine)
Specialties:
Pediatrics, Clinical Cytogenetics, Clinical Genetics, Clinical Molecular Genetics
Address:
12902 Usf Magnolia Dr, Tampa 33612
(813) 745-4673 (Phone)
Life Time Cancer Screening
4117 E Fowler Ave, Tampa 33617
(813) 745-6769 (Phone)
(813) 745-4673 (Phone)
Life Time Cancer Screening
4117 E Fowler Ave, Tampa 33617
(813) 745-6769 (Phone)
Certifications:
Clinical Cytogenetics, 2009, Clinical Genetics, 2009, Clinical Molecular Genetics, 2010, Pediatrics, 1993
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Education:
Medical School
Temple University School Of Medicine
Graduated: 1990
All Childns Hospital University South Fla College Med
Graduated: 1991
Graduated: 1993
University South Fla College Med
Graduated: 1996
Temple University School Of Medicine
Graduated: 1990
All Childns Hospital University South Fla College Med
Graduated: 1991
Graduated: 1993
University South Fla College Med
Graduated: 1996
Methods For Detecting Or Monitoring Cancer Using Lpc As A Marker
US Patent:
2010029, Nov 18, 2010
Filed:
Nov 5, 2008
Appl. No.:
12/734117
Inventors:
Lian Shan - Broadview Heights OH, US
Rebecca Sutphen - Tampa FL, US
Rebecca Sutphen - Tampa FL, US
International Classification:
G01N 33/487
US Classification:
436 64
Abstract:
A method of detecting a cancer, such as ovarian cancer, in a test subject including (a) determining the amount of a lysophosphatidyl choline in a sample of a bodily fluid taken from the test subject, and (b) comparing the amount of the lysophosphatidyl choline in the sample of the bodily fluid taken from the test subject to a range of amounts of lysophosphatidyl choline found in samples of the bodily fluid taken from a group of normal subjects of the same species as the test subject and lacking the cancer, such as ovarian cancer, whereby a change in the amount of the lysophosphatidyl choline in the sample of the bodily fluid taken from the test subject indicates the presence of the cancer, such as ovarian cancer.
Methods For Detecting Or Monitoring Cancer Using Lpe As A Marker
US Patent:
8133736, Mar 13, 2012
Filed:
May 7, 2010
Appl. No.:
12/775958
Inventors:
Lian Shan - Ithaca NY, US
Lorelei D. Davis - East Lansing MI, US
Rebecca Sutphen - Tampa FL, US
Lorelei D. Davis - East Lansing MI, US
Rebecca Sutphen - Tampa FL, US
Assignee:
University of South Florida - Tampa FL
International Classification:
G01N 33/92, G01N 33/48
US Classification:
436 64, 436 63, 436 71
Abstract:
A method of detecting a cancer, such as ovarian cancer, in a test subject including (a) determining the amount of a lysophosphatidyl ethanolamine in a sample of a bodily fluid taken from the test subject, and (b) comparing the amount of the lysophosphatidyl ethanolamine in the sample of the bodily fluid taken from the test subject to a range of amounts of the lysophosphatidyl ethanolamine found in samples of the bodily fluid taken from a group of normal subjects of the same species as the test subject and lacking the cancer, such as ovarian cancer, whereby a change in the amount of the lysophosphatidyl ethanolamine in the sample of the bodily fluid from the test subject indicates the presence of the cancer, such as ovarian cancer.
Rebecca Sutphen, Tampa FL
Specialties:
Pediatrics, Clinical Genetics, M.D., Clinical Molecular Genetics, Clinical Cytogenetic
Work:
HLMCC Lifetime Cancer Screening Center
12902 Usf Magnolia Dr, Tampa, FL 33612 H Lee Moffitt Cancer Ctr
4117 E Fowler Ave, Tampa, FL 33617 All Children's Hospital
880 6Th St S, Saint Petersburg, FL 33701
12902 Usf Magnolia Dr, Tampa, FL 33612 H Lee Moffitt Cancer Ctr
4117 E Fowler Ave, Tampa, FL 33617 All Children's Hospital
880 6Th St S, Saint Petersburg, FL 33701
Education:
Temple University Physicians (1990) Pediatrics
Novel Gold Nanoparticle Aggregates And Their Applications
US Patent:
2008016, Jul 10, 2008
Filed:
Mar 30, 2006
Appl. No.:
11/396098
Inventors:
Jin Zhang - Santa Cruz CA, US
Adam Schwartzberg - Santa Cruz CA, US
Thaddeus Norman - San Jose CA, US
Tammy Y. Oshiro - Santa Cruz CA, US
Christian D. Grant - San Jose CA, US
Rebecca Sutphen - Tampa FL, US
Leo Seballos - Santa Cruz CA, US
Yi Zhang - Santa Cruz CA, US
Claire Gu - Santa Cruz CA, US
Adam Schwartzberg - Santa Cruz CA, US
Thaddeus Norman - San Jose CA, US
Tammy Y. Oshiro - Santa Cruz CA, US
Christian D. Grant - San Jose CA, US
Rebecca Sutphen - Tampa FL, US
Leo Seballos - Santa Cruz CA, US
Yi Zhang - Santa Cruz CA, US
Claire Gu - Santa Cruz CA, US
International Classification:
C12Q 1/68, C12M 1/34, G01N 33/551
US Classification:
435 6, 436524, 4352872, 977902, 977924
Abstract:
The invention is drawn to novel gold nanoparticles that are used in a dual optical method for sensitive and selective detection of antigens. The gold nanoparticle aggregates are synthesized from gold hydrochloride and sulfur salts in an aqueous solution. The aggregates can be selectively sized using a spectral notch filter that results in an improved product with versatile uses. The gold nanoparticles can also be used in improved optical communications devices.
Luminescence Characterization Of Quantum Dots Conjugated With Biomarkers For Early Cancer Detection
US Patent:
2006000, Jan 5, 2006
Filed:
Jun 30, 2005
Appl. No.:
11/160617
Inventors:
Tatyana Zhukov - Lutz FL, US
Sergei Ostapenko - Wesley Chapel FL, US
Rebecca Sutphen - Tampa FL, US
Johnathan Lancaster - Tampa FL, US
Thomas Sellers - Tampa FL, US
Jin Zhang - Santa Cruz CA, US
Sergei Ostapenko - Wesley Chapel FL, US
Rebecca Sutphen - Tampa FL, US
Johnathan Lancaster - Tampa FL, US
Thomas Sellers - Tampa FL, US
Jin Zhang - Santa Cruz CA, US
Assignee:
UNIVERSITY OF SOUTH FLORIDA - Tampa FL
International Classification:
G01N 33/551
US Classification:
436524000
Abstract:
Luminescent semiconductor quantum dots (QDs) conjugated with biomolecules to serve as sensitive probes for early detection of the cancer cells, specifically for ovarian cancer and lung cancer, which represents the most lethal malignancies. The luminescence characterization of the bin-conjugated QDs with cancer specific antigens using linkage molecules. Photo-enhancement is measured at various laser density power, temperatures and laser wavelengths.
Methods And Materials For Detection, Diagnosis And Management Of Ovarian Cancer
US Patent:
2010019, Jul 29, 2010
Filed:
Jan 25, 2008
Appl. No.:
12/524537
Inventors:
Rebecca Sutphen - Tampa FL, US
Johnathan Mark Lancaster - Tampa FL, US
Johnathan Mark Lancaster - Tampa FL, US
International Classification:
C40B 40/10, G01N 33/53, G01N 33/50
US Classification:
506 18, 435 71, 436 86, 435 792
Abstract:
The subject invention concerns methods using a panel of proteins to detect, diagnose, and monitor therapy during treatment of ovarian cancer in a female patient. The proteins were identified using proteomics analyses of plasma samples obtained preoperatively from ovarian cancer patients versus those of healthy control women. Such a panel has utility for the diagnosis of ovarian cancer, screening for ovarian cancer and possibly therapeutic monitoring.